What is clinically relevant? [Design Issues]

posted by bebac_fan – US, 2018-04-06 22:53 (1886 d 17:10 ago) – Posting: # 18648
Views: 5,084

Dear Helmut:

I believe the spaghetti plots you posted are actually indicative of a infusion of unbound drug.

Release of the encapsulated form follows first order kinetics and is Sequential - kind of like metabolic clearance from parent --> metabolite.

Luckily, you also posted the parent/metabolite curve for doxorubinol. Because of similarity in process, if no free drug is infused, bound and unbound PK should follow the same general shape we see in parent + metabolite.

The fact that total + free dox concentrations are colinear is pretty strong evidence for co-infusion of bound + unbound. Further, the fact that there isn't a lag time in unbound, as well as a nonlinear shape, is evidence, too.


Complete thread:

UA Flag
 Admin contact
22,618 posts in 4,741 threads, 1,611 registered users;
24 visitors (0 registered, 24 guests [including 10 identified bots]).
Forum time: 16:03 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz